REGISTERED
on 23 Apr 2024
Last Applicant/ Owned by
SAFFRON WALDEN Essex CB10 1XL
GB
Serial Number
79327240 filed on 28th Sep 2021
Registration Number
7361956 registered on 23rd Apr 2024
Correspondent Address
Amanda M. Prose
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
ARECOR
Medical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines Medical preparations, namely, diagnostic preparations for medical purposes, preparations for the treatment of viral, metabo Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medical preparations, namely, diagnostic preparations for medical purposes, preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Medicinal products, namely, pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Pharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Biopharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infectives, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79327240
Mark Type
No Service Mark
Attorney Docket Number
No A269.6000US1
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Nov 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 22nd Oct 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 21st Oct 2024 | FINAL DISPOSITION PROCESSED |
| 24th Jul 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 23rd Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
| 06th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 05th Feb 2024 | NOTIFICATION PROCESSED BY IB |
| 17th Jan 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |